Cerebral microglia activation in hepatitis C virus infection correlates to cognitive dysfunction

H. Pflugrad, G-J. Meyer, M. Dirks, P. Raab, A. B. Tryc, A. Goldbecker, H. Worthmann, F. Wilke, R. Boellaard, M. Yaqub, G. Berding, K. Weissenborn

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Hepatitis C virus (HCV) infection may induce chronic fatigue and cognitive dysfunction. Virus replication was proven within the brain and HCV‐positive cells were identified as microglia and astrocytes. We hypothesized that cerebral dysfunction in HCV‐afflicted patients is associated with microglia activation. Microglia activation was assessed in vivo in 22 patients with chronic HCV infection compared to six healthy controls using [11C]‐PK11195 Positron Emission Tomography (PET) combined with magnetic resonance tomography for anatomical localization. Patients were subdivided with regard to their PCR status, Fatigue Impact Scale score (FIS) and attention test sum score (ATS). A total of 12 patients (54.5%) were HCV PCR positive [of which 7 (58.3%) had an abnormal FIS and 7 (58.3%) an abnormal ATS], 10 patients (45.5%) were HCV PCR negative (5 (50%) each with an abnormal FIS or ATS). Patients without attention deficits showed a significantly higher accumulation of [11C]‐PK11195 in the putamen (P = 0.05), caudate nucleus (P = 0.03) and thalamus (P = 0.04) compared to controls. Patients with and without fatigue did not differ significantly with regard to their specific tracer binding in positron emission tomography. Preserved cognitive function was associated with significantly increased microglia activation with predominance in the basal ganglia. This indicates a probably neuroprotective effect of microglia activation in HCV‐infected patients.
Original languageEnglish
Pages (from-to)348-357
JournalJournal of Viral Hepatitis
Volume23
Issue number5
DOIs
Publication statusPublished - May 2016

Cite this